Methylation of CpG island promoters in uveal melanoma

The British Journal of Ophthalmology
A P MoulinJ Benhattar

Abstract

Inactivation of tumour-related genes by promoter hypermethylation is a common epigenetic event in the development of a variety of tumours. To investigate in primary uveal melanoma the status of promoter methylation of genes thought to be involved in tumour development: p16, TIMP3, RASSF1, RARB, FHIT, hTERT and APC. Gene promoter methylation was studied by methylation-sensitive single-strand conformation analysis and dot-blot assay in a series of 23 primary uveal melanomas. All DNA samples were obtained from paraffin-embedded formalin-fixed tissue blocks. hTERT promoter methylation was found with a relatively high frequency (52%). Promoter methylation of p16, TIMP3, RASSF1, RARB, FHIT and APC was a rare event. For none of these genes did promoter methylation exceed 15% of tumour samples, and, for some genes (FHIT and APC), no methylation was found at all. Furthermore, promoter methylation was absent in 39% (9/23) of cases. In only 22% (5/23) of cases was hypermethylation of at least two promoters observed. Promoter methylation of hTERT is a regular event in uveal melanoma. Hypermethylation of the other genes studied does not seem to be an essential element in the development of this tumour. As promoter methylation of APC, RASSF1...Continue Reading

Citations

Sep 1, 2011·Journal of Ocular Biology, Diseases, and Informatics·Deborah C Otteson
Dec 12, 2012·Eye·S E CouplandB E Damato
Dec 17, 2008·Pharmacogenomics·George W M Millington
Feb 18, 2012·Future Oncology·Pierre L Triozzi, Arun D Singh
Jul 16, 2010·Dermatology Research and Practice·Thomas van den BoschAnnelies de Klein
Dec 10, 2013·Journal of Cellular Physiology·Biao YanQin Jiang
Dec 17, 2014·Biochimica Et Biophysica Acta·Mario VenzaIsabella Venza
Sep 14, 2017·Clinical Genetics·A SharmaM C Herwig-Carl
Mar 27, 2018·Chinese Medical Journal·Zhi-Kun YangWei-Hong Yu
Jul 31, 2020·International Journal of Molecular Sciences·Pooneh Chokhachi BaradaranBozena Smolkova
Mar 29, 2011·Journal français d'ophtalmologie·N Abi-AyadJ Couturier

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.